Sex Difference in OA: Should We Blame Estrogen?

Eur J Rheumatol · 2023 · PMC11664844 · PMID 36688799

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

36 Progression of OA Current use of estrogen from the Framingham OA Study 35 also showed a trend toward decreased risk of progressive knee compared with never use (OR = 0.5, 95% CI: 0.1-2.9), but results were not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.